*
Skip to main content

Apple Vision Pro takes a leap with brain-computer interface capability

The Vision Pro headset from Apple is now capable of being controlled solely through the power of thoughts.
Apple Vision Pro takes a leap with brain-computer interface capability

The Vision Pro headset from Apple is now capable of being controlled solely through the power of thoughts, all thanks to its integration with the brain-computer interface (BCI) developed by the neurotechnology startup Synchron.

Also Read: Sony rolls out Astro Bot special edition PS5 DualSense controller

The firm revealed that a patient has effectively utilized the Apple Vision Pro via direct brain control, made possible by Synchron's brain-computer interface technology. Mark, a 64-year-old diagnosed with amyotrophic lateral sclerosis (ALS), showcased this integration.

Mark utilized this technology to operate the cursor on the Vision Pro, enabling him to engage in activities such as playing Solitaire, watching Apple TV, and sending text messages without the use of his hands, which are immobile due to his condition. The Vision Pro's dependence on hand gestures could have been a hindrance for individuals like Mark who lack upper limb mobility, reports MacRumors.

Mark has been honing various abilities and functionalities with his BCI twice a week ever since it was implanted in August 2023. He observed that operating the Vision Pro through the BCI is akin to using it with his iPhone, iPad, and computer. Apple's array of accessibility features on its platforms has garnered acclaim for its quality, prompting Synchron to prioritize compatibility with Apple devices from the outset.

Synchron's brain-computer interface enables people with significant physical disabilities to operate electronic devices using their brain activity. The BCI is surgically placed in a blood vessel located on the outer layer of the motor cortex through a minimally invasive endovascular technique. By capturing signals of motor intentions from the brain, the device sends these wirelessly to external gadgets, allowing for hands-free manipulation.

Synchron is gearing up for extensive clinical trials aimed at broadening the application of its brain-computer interface (BCI) technology. The company has successfully implanted its BCI in six patients in the United States and four in Australia. Additionally, Synchron is actively pursuing approval from the U.S. Food and Drug Administration to bring its technology to market.

Also Read: Meta Quest 3 set to receive Meta AI Vision and Advanced Chatbot features

Recommended For You

Trending on Mashable

  翻译: